Answers are grounded in this paper and cite their sources.
Case report demonstrates persistent fever from drug-resistant Salmonella Typhi resolving after combination therapy in a traveler, highlighting potential occult carbapenemase activity.
Salmonella Typhi remains a global health concern, particularly in travelers returning from endemic regions. We report a 32-year-old male with persistent fever after travel to Iraq. Initial investigations were inconclusive, but cultures later identified ESBL-producing S. Typhi resistant to ceftriaxone, fluoroquinolones, and TMP-SMX, but susceptible to meropenem. Fever persisted despite meropenem and resolved only after azithromycin was added. Standard testing showed no carbapenem resistance, suggesting possible undetected low-level carbapenemase activity. This case highlights the need for heightened clinical suspicion, use of advanced diagnostics, and consideration of combination therapy in prolonged typhoid fever, especially in returning travelers from high-resistance regions.
No takes yet. Share an insight, caveat, or question.
Fakherddine et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: